Business Deals
Why Takeda has bet the farm on Shire
Japanese drug powerhouse desperate for foothold in US market
Welcome to our new website
As well as being able to load content faster than ever before, you'll now find it's much easier to find all the content you need about the Asian business world.
Pharmaceuticals
Business Deals
Takeda's $60bn offer for Shire rejected as too low
'More attractive' proposal requested for would-be record acquisition
Companies
Pharma giant Astellas to invest $1.8bn in M&A diversification bid
Japanese company scouts startups for new drugs as old patents set to expire
Business Deals
Malaysia's IHH eyes India expansion with bid for local hospital group
Offer for Fortis Healthcare is higher than rival consortiums
Equities
India stocks edge higher, paced by Housing Development, ITC
Gains in index heavyweights offset losses in Infosys, Tata Motors
Business Deals
A Takeda bid for Shire hinges on outside directors' nod
Japanese drugmaker hurries to raise money for a potential megadeal
Equities
India shares advance for sixth day as software exporters gain
Infosys, Tata Consultancy rise ahead of earnings
Companies
Takeda looks to raise funds for potential Shire acquisition
Drugmaker will need up to 7tn yen to purchase 100% stake in Irish company
Business Deals
Investors hammer Takeda's plan for $55bn acquisition
Japanese drugmaker's stock slumps 10% in less than two weeks
Equities
India shares outperform regional peers with best weekly gains in two months
Automakers, banks gain, helping offset trade war concerns
